Literature DB >> 3896593

Is aldosterone/renin ratio useful to screen a hypertensive population for primary aldosteronism?

S M Hamlet, T J Tunny, E Woodland, R D Gordon.   

Abstract

The ratio of aldosterone to renin in plasma was measured in samples collected from 79 hypertensive patients. Eighteen patients with primary aldosteronism had ratios ranging from 25 to 677 (mean 183) when measured on 34 occasions, while 16 normal subjects had ratios of 3.3-21 (mean 11.3). Of the remaining 61 patients with ratios ranging from 1.8 to 184, 15 patients have ratios greater than 25 and are under investigation for primary aldosteronism, which appears highly likely in five and has been excluded in two. The aldosterone/renin ratio appears promising as a screening test for primary aldosteronism. Consistency and the effects of sodium and potassium balance and of antihypertensive medications require further study.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3896593     DOI: 10.1111/j.1440-1681.1985.tb02641.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  6 in total

Review 1.  Hyperaldosteronism: recent concepts, diagnosis, and management.

Authors:  R Foo; K M O'Shaughnessy; M J Brown
Journal:  Postgrad Med J       Date:  2001-10       Impact factor: 2.401

Review 2.  Primary aldosteronism: rare bird or common cause of secondary hypertension?

Authors:  M Stowasser
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 3.  Primary aldosteronism.

Authors:  R D Gordon
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

Review 4.  Pathogenesis of Familial Hyperaldosteronism Type II: New Concepts Involving Anion Channels.

Authors:  Michael Stowasser; Martin Wolley; Aihua Wu; Richard D Gordon; Julia Schewe; Gabriel Stölting; Ute I Scholl
Journal:  Curr Hypertens Rep       Date:  2019-04-04       Impact factor: 5.369

5.  Surgical treatment of primary hyperaldosteronism.

Authors:  R J Weigel; S A Wells; J C Gunnells; G S Leight
Journal:  Ann Surg       Date:  1994-04       Impact factor: 12.969

6.  Activating mutations in CTNNB1 in aldosterone producing adenomas.

Authors:  Tobias Åkerström; Rajani Maharjan; Holger Sven Willenberg; Kenko Cupisti; Julian Ip; Ana Moser; Peter Stålberg; Bruce Robinson; K Alexander Iwen; Henning Dralle; Martin K Walz; Hendrik Lehnert; Stan Sidhu; Celso Gomez-Sanchez; Per Hellman; Peyman Björklund
Journal:  Sci Rep       Date:  2016-01-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.